CA1341619C - Recombinant inhibin - Google Patents

Recombinant inhibin

Info

Publication number
CA1341619C
CA1341619C CA506791A CA506791A CA1341619C CA 1341619 C CA1341619 C CA 1341619C CA 506791 A CA506791 A CA 506791A CA 506791 A CA506791 A CA 506791A CA 1341619 C CA1341619 C CA 1341619C
Authority
CA
Canada
Prior art keywords
amino acids
subunit
inhibin
ser
ile
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA506791A
Other languages
English (en)
French (fr)
Inventor
Robert Gregory Forage
Andrew George Stewart
David Mark Milne-Robertson
David Morritz De Kretser
John Kerr Findlay
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Monash Medical Centre
St Vincents Institute of Medical Research
Inhibin Pty Ltd
Monash University
Original Assignee
Monash Medical Centre
St Vincents Institute of Medical Research
Inhibin Pty Ltd
Monash University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27507359&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CA1341619(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Monash Medical Centre, St Vincents Institute of Medical Research, Inhibin Pty Ltd, Monash University filed Critical Monash Medical Centre
Application granted granted Critical
Publication of CA1341619C publication Critical patent/CA1341619C/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Wood Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CA506791A 1985-04-18 1986-04-16 Recombinant inhibin Expired - Fee Related CA1341619C (en)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
AU(PH0194) 1985-04-18
AUPH019485 1985-04-18
AU(PH2320) 1985-09-06
AUPH232085 1985-09-06
AU(PH3157) 1985-09-29
AUPH315785 1985-10-29
AU(PH3960) 1985-12-19
AUPH396085 1985-12-19
AUPH396185 1985-12-20
AU(PH3961) 1985-12-20
PCT/AU1986/000097 WO1986006076A1 (en) 1985-04-18 1986-04-14 Recombinant inhibin

Publications (1)

Publication Number Publication Date
CA1341619C true CA1341619C (en) 2011-08-02

Family

ID=27507359

Family Applications (1)

Application Number Title Priority Date Filing Date
CA506791A Expired - Fee Related CA1341619C (en) 1985-04-18 1986-04-16 Recombinant inhibin

Country Status (11)

Country Link
US (1) US6613891B1 (2)
EP (1) EP0218717B1 (2)
JP (1) JP3213470B2 (2)
KR (1) KR940004077B1 (2)
CA (1) CA1341619C (2)
DE (1) DE3650689T2 (2)
DK (1) DK173446B1 (2)
IL (1) IL78519A (2)
IN (1) IN165453B (2)
NZ (1) NZ215829A (2)
WO (1) WO1986006076A1 (2)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1341617C (en) * 1984-06-08 2011-06-28 Henry George Burger Inhibin isolated from ovarian follicular fluid
JPH0637520B2 (ja) * 1985-07-03 1994-05-18 味の素株式会社 ポリペプチド
US5089396A (en) * 1985-10-03 1992-02-18 Genentech, Inc. Nucleic acid encoding β chain prodomains of inhibin and method for synthesizing polypeptides using such nucleic acid
US5215893A (en) * 1985-10-03 1993-06-01 Genentech, Inc. Nucleic acid encoding the ba chain prodomains of inhibin and method for synthesizing polypeptides using such nucleic acid
NZ217727A (en) * 1985-10-03 1990-05-28 Genentech Inc Nucleic acid encoding alpha or b chain of inhibin, its production and compositions containing it
AU599373B2 (en) * 1986-03-13 1990-07-19 Biotechnology Australia Proprietary Limited Method of assay of inhibin
WO1988000208A1 (en) * 1986-06-24 1988-01-14 The Salk Institute For Biological Studies Ovine inhibin
EP0368992B1 (en) * 1988-05-31 1995-02-15 Biotechnology Australia Pty. Ltd. Actions of hormones
US5071834A (en) * 1988-09-16 1991-12-10 Genentech, Inc. Purified activin B composition
US5942220A (en) * 1990-03-16 1999-08-24 Chiron Corporation Inhibitor of cytokine activity and applications thereof
US6043212A (en) * 1993-07-26 2000-03-28 Cor Therapeutics, Inc. Recombinant C140 receptor, its agonists and antagonists, and nucleic acids encoding the receptor
AUPO638897A0 (en) * 1997-04-23 1997-05-22 Monash University Modulation of cell growth and methods relating thereto
AU8579298A (en) * 1997-07-31 1999-02-22 Johns Hopkins University School Of Medicine, The Growth differentiation factor-16
EP1163365A4 (en) 1999-02-25 2002-11-20 Auckland Uniservices Ltd DIAGNOSIS AND THERAPY OF EARLY OVARY FAILURE
EP1389997B1 (en) * 2001-04-13 2010-12-08 Boyce Thompson Institute For Plant Research Methods and compositions for stable transgenic plant pharmaceuticals and their use as contraceptives
CN102409065B (zh) * 2011-06-28 2014-05-21 中国农业科学院北京畜牧兽医研究所 一种提高动物繁育力的新型shRNA及其应用
BR102014005376A2 (pt) * 2014-03-07 2016-02-10 Ouro Fino Saúde Animal Ltda antígeno de inibina alfa, gene codificante de inibina alfa, gene codificante de proteína de fusão, processo de obtenção do antígeno de inibina alfa, composição antigênica, uso do antígeno de inibina alfa e uso da composição antigênica
CN105296493B (zh) * 2015-11-13 2020-09-11 北京农学院 一种牛抑制素α亚基成熟肽基因及重组表达蛋白质的方法
CN108588100B (zh) * 2018-05-09 2021-07-16 广州市达瑞生物技术股份有限公司 一种抑制素b双基因片段联合表达载体及其应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4399216A (en) 1980-02-25 1983-08-16 The Trustees Of Columbia University Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
US4717666A (en) 1984-03-05 1988-01-05 Smithkline Beckman Corporation Cloned streptomycete lividans excretable β-galactosidase gene
JPS60501592A (ja) 1983-06-20 1985-09-26 バッテル・メモリアル・インスティチュート 高速マルチソリツド流動床法
US4643969A (en) 1983-07-25 1987-02-17 The Research Foundation Of State University Of New York Novel cloning vehicles for polypeptide expression in microbial hosts
EP0154434B1 (en) * 1984-02-17 1993-01-27 Genentech, Inc. Human transforming growth factor and precursor or fragment thereof, cells, dna, vectors and methods for their production, compositions and products containing them, and related antibodies and diagnostic methods
US4636463A (en) * 1984-04-05 1987-01-13 Scripps Clinic And Research Foundation Antibodies to human interleukin-2 induced by synthetic polypeptides
CA1341617C (en) 1984-06-08 2011-06-28 Henry George Burger Inhibin isolated from ovarian follicular fluid
JPH0730114B2 (ja) * 1985-04-03 1995-04-05 正雄 五十嵐 インヒビン
US4624944A (en) 1985-06-14 1986-11-25 The Regents Of The University Of California Human seminal alpha-inhibins
US4740587A (en) 1985-07-18 1988-04-26 The Salk Institute For Biological Studies Inhibin and method of purifying same
NZ217727A (en) * 1985-10-03 1990-05-28 Genentech Inc Nucleic acid encoding alpha or b chain of inhibin, its production and compositions containing it
US4798885A (en) 1986-02-07 1989-01-17 Genentech, Inc. Compositions of hormonally active human and porcine inhibin containing an α chain and 62 chain
US4864019A (en) * 1985-11-08 1989-09-05 The Salk Institute For Biological Studies Antibodies to inhibin and conjugates produced therefrom
US4737578A (en) 1986-02-10 1988-04-12 The Salk Institute For Biological Studies Human inhibin
US5011691A (en) 1988-08-15 1991-04-30 Stryker Corporation Osteogenic devices

Also Published As

Publication number Publication date
JP3213470B2 (ja) 2001-10-02
EP0218717A4 (en) 1990-04-10
NZ215829A (en) 1991-11-26
US6613891B1 (en) 2003-09-02
DE3650689T2 (de) 1999-04-08
WO1986006076A1 (en) 1986-10-23
DK611386D0 (da) 1986-12-18
IL78519A (en) 1992-01-15
EP0218717B1 (en) 1998-07-15
DK173446B1 (da) 2000-11-06
KR870700633A (ko) 1987-12-30
KR940004077B1 (ko) 1994-05-11
DE3650689D1 (de) 1998-08-20
IN165453B (2) 1989-10-21
IL78519A0 (en) 1986-08-31
JPH07188296A (ja) 1995-07-25
DK611386A (da) 1987-02-18
EP0218717A1 (en) 1987-04-22

Similar Documents

Publication Publication Date Title
CA1341619C (en) Recombinant inhibin
KR20000029911A (ko) ＧｎＲＨ-류코톡신키메라
KR100293025B1 (ko) 고나도트로핀방출호르몬에대한면역원성캐리어시스템
CA2255888A1 (en) Modulating the activity of hormones or their receptors - peptides, antibodies, vaccines and uses thereof
EP1129724B1 (en) Vaccines for treating colon cancer
KR20020006720A (ko) 이황화결합으로 연결된 당단백질 호르몬 유사체, 이의제조방법 및 이의 용도
CN115066256A (zh) 用于动物绝育或阉割的重组蛋白及包含该重组蛋白的疫苗组合物
WO1991016922A1 (en) Analogs of glycoprotein hormones having altered immunological characteristics, efficacy and/or receptor specificity
EP0439056B1 (en) Coccidiosis vaccines
CA2040441C (en) Fusion proteins
CA1057742A (en) Antigenic modification of polypeptides
US6037321A (en) Fusion proteins comprising vasoactive intestinal peptide or PACAP
HUT52787A (en) Process for production of biologically active peptides
JP2652534B2 (ja) 組換えインヒビン
AU5903986A (en) Recombinant inhibin
Sahal et al. Immunobiological properties of a carboxy-terminal 53-amino acid peptide of the beta subunit of human chorionic gonadotropin
AU704010B2 (en) Novel peptides useful in enhancement of FSH action
Guémené et al. Development and validation of a homologous radioimmunoassay using a biologically active recombinant turkey prolactin
AU622044B2 (en) Fusion proteins
JP2787926B2 (ja) 融合タンパク質
KR100226985B1 (ko) 신규한 인간성장호르몬방출인자-인간상피세포성장인자 융합유전자, 이의 발현벡터 및 이를 이용한 인간성장호르몬방출인자의 제조방법
CA1085383A (en) Antigenic modification of polypeptides
WO1997029184A1 (en) Estrogen response element binding proteins and nucleotides encoding therefor
CN100415299C (zh) 胚泡着床相关因子及其用途
CN100384481C (zh) 胚泡着床相关因子及其用途

Legal Events

Date Code Title Description
MKLA Lapsed

Effective date: 20210803